Haplnscience

Developer of drugs for anti-ageing and osteoarthritis treatment

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2018 groups16 employees language haplnscience.com

Innovation

15 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport, Physics & computing; filing pace slowing. Cited 323 times.

YearFilings
20181
20191
20206
20219
20227
20236
20247
20252
20261

Investor mix

9 investors on record; lead investors include DSC Investment, Company K Partners, Korea Technology Finance.

Investor typeCountShare
Venture capital778%
Accelerator & incubator222%
Coming soon